Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4. [electronic resource]
Producer: 20160913Description: e0153895 p. digitalISSN:- 1932-6203
- Adult
- Antiviral Agents -- therapeutic use
- Biomarkers -- metabolism
- CTLA-4 Antigen -- genetics
- Drug Therapy, Combination
- Female
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- therapeutic use
- Interferons
- Interleukins -- genetics
- Male
- Polyethylene Glycols -- therapeutic use
- Polymerase Chain Reaction
- Polymorphism, Single Nucleotide -- genetics
- Programmed Cell Death 1 Receptor -- genetics
- ROC Curve
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.